Publications

Export 79 results:
Filtres: Author is M-A Roy  [Enlever les filtres]
2020
M. - A. Nolin, Demers, M. - F., Rauzier, C., Bouchard, R. - H., Cadrin, C., Després, J. - P., M-A Roy, Alméras, N., et Picard, F., « Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics. », World J Biol Psychiatry, p. 1-8, 2020.
M-A Roy, « The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017. », Can J Psychiatry, vol. 65, nᵒ 7, p. 510-511, 2020.
E. Stip, Grignon, S., M-A Roy, Bloom, D., Osman, O., Amiri, L., Aziz, K. Abdul, Javaid, S. Fahad, et Arnone, D., « From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs). », Expert Rev Neurother, 2020.
P. Gagnon, Gaudreau, J. - D., M-A Roy, et Moreau, J. Le Moignan, « Letter to the Editor: Correction About the Nursing Delirium Screening Scale in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium". », Psychosomatics, 2020.
Y. C. Chagnon, Maziade, M., Paccalet, T., Croteau, J., Fournier, A., M-A Roy, et Bureau, A., « A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds. », Eur J Hum Genet, vol. 28, nᵒ 4, p. 499-507, 2020.
W. Pothier, M-A Roy, Corbière, M., Thibaudeau, É., Achim, A., Wykes, T., Reeder, C., Chagnon, Y., et Cellard, C., « Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis. », Neurocase, vol. 26, nᵒ 6, p. 340-352, 2020.
O. Corbeil, Corbeil, S., Giroux, I., Jacques, C., Dorval, M., Demers, M. - F., et M-A Roy, « Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports. », J Clin Psychopharmacol, vol. 40, nᵒ 2, p. 191-194, 2020.
V. Ferraro, Lafrenière, S., Demers, M. - F., M-A Roy, et Abdel-Baki, A., « "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients. », Psychopharmacology (Berl), 2020.

Financement / Soutien / Partenaires

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord